Nexome Capital Markets Board Meeting on May 25 to Consider FY26 Final Dividend

1 min read     Updated on 13 May 2026, 11:07 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) has rescheduled its board meeting to May 25, 2026, from the original date of May 11, 2026, to consider a final dividend for FY26 and approve audited financial results for the quarter and year ended March 31, 2026. The dividend, if approved by shareholders at the ensuing AGM, will be paid within 30 days of such approval, subject to applicable tax deductions. The trading window for designated persons will remain closed until 48 hours after the declaration of results and dividend recommendation.

powered bylight_fuzz_icon
39556002

*this image is generated using AI for illustrative purposes only.

Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) has informed BSE Limited that its Board of Directors will meet on Monday, May 25, 2026, to consider and recommend a final dividend for the financial year ended March 31, 2026. In continuation of its earlier intimation dated May 08, 2026, the company confirmed the rescheduled meeting pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting was originally scheduled for May 11, 2026, but was rescheduled due to the non-availability of directors.

Revised Board Meeting Details

The meeting is scheduled to be held at 03:30 P.M. at the company's registered office located at 'Vaibhav' (4F), 4, Lee Road, Kolkata – 700020. The key details regarding the updated schedule are outlined below:

Parameter: Details
Original Meeting Date: Monday, May 11, 2026
Revised Meeting Date: Monday, May 25, 2026
Revised Meeting Time: 03:30 P.M.
Venue: 'Vaibhav' (4F), 4, Lee Road, Kolkata – 700020
Regulatory Reference: Regulation 29, SEBI LODR Regulations, 2015

Agenda of the Meeting

The Board will deliberate on the following key items:

  • Consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Consider recommendation of a final dividend on the equity shares of the Company for the financial year ended March 31, 2026, subject to the provisions of Section 123 of the Companies Act, 2013 and Regulation 43 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. If approved by shareholders at the ensuing AGM, the dividend shall be paid within 30 days from the date of such approval, subject to applicable tax deductions at source.
  • Any other matter, if required, with the permission of the chair.

Trading Window Closure

In accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window for dealing in the securities of Nexome Capital Markets Limited shall remain closed for all Designated Persons and their immediate relatives until 48 hours after the declaration of the financial results and dividend recommendation.

Historical Stock Returns for Nexome Capital Markets

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+25.26%+11.18%+25.81%+55.72%+252.83%

What dividend per share is Nexome Capital Markets likely to recommend for FY2026, and how might it compare to previous years' payouts?

How has the rebranding from SMIFS Capital Markets to Nexome Capital Markets impacted investor sentiment and the company's market positioning?

What key financial metrics from the FY2026 audited results could signal the company's growth trajectory in the capital markets sector?

like16
dislike

BSE Grants Listing Approval to Nexome Capital Markets for 19,20,000 Preferential Equity Shares

2 min read     Updated on 07 May 2026, 11:06 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

BSE Limited granted listing approval on May 07, 2026, to Nexome Capital Markets Limited for 19,20,000 equity shares of Rs. 10/- each, issued at a premium of Rs. 54/- per share on a preferential basis via warrant conversion. The shares, bearing distinctive numbers from 88,15,501 to 1,07,35,500, were allotted to both Promoter and Non-Promoter categories. Trading approval remains contingent on the company submitting requisite confirmations from NSDL/CDSL and, if applicable, a listing approval from NSE. The company must also apply for trading approval within seven working days of the listing approval date, as per SEBI's circular dated June 21, 2023.

powered bylight_fuzz_icon
39720987

*this image is generated using AI for illustrative purposes only.

Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) has received listing approval from BSE Limited for 19,20,000 equity shares issued on a preferential basis through the conversion of warrants. The approval, communicated via BSE reference LOD/PREF/GB/FIP/195/2026-27 dated May 07, 2026, marks a significant step in the company's capital restructuring exercise under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the Preferential Allotment

The newly listed shares carry a face value of Rs. 10/- each and were issued at a premium of Rs. 54/- per share. The allotment covers both Promoter and Non-Promoter categories, with the shares assigned distinctive numbers from 88,15,501 to 1,07,35,500. The table below summarises the key parameters of this preferential issue:

Parameter: Details
Number of Shares: 19,20,000 equity shares
Face Value: Rs. 10/- per share
Issue Premium: Rs. 54/- per share
Distinctive Numbers: 88,15,501 to 1,07,35,500
Allottee Category: Promoter and Non-Promoters
Basis of Issue: Preferential allotment via warrant conversion
BSE Approval Reference: LOD/PREF/GB/FIP/195/2026-27
Date of Approval: May 07, 2026

Regulatory Compliance Requirements

BSE has outlined several conditions that Nexome Capital Markets must fulfil before trading approval is granted for these shares. The exchange has directed the company to ensure compliance with Regulation 167 of SEBI (ICDR) Regulations and any subsequent SEBI directives. Additionally, in the event of a change exceeding two per cent of the total paid-up share capital, the company is required to file the shareholding pattern in XBRL mode as mandated under Regulation 31(1)(c) of SEBI LODR Regulations, 2015.

Conditions Precedent to Trading Approval

Trading approval for the aforementioned shares will be granted only upon the company submitting the following to BSE:

  • Listing approval from the National Stock Exchange of India Ltd. (if applicable)
  • Confirmation letters from NSDL/CDSL confirming the crediting of shares to respective beneficiary accounts or admission of capital to the depository system
  • Confirmation letters from NSDL/CDSL regarding lock-in of pre-preferential holding (if applicable)

Further, as per Schedule XIX of ICDR Regulations and SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, Nexome Capital Markets is required to apply for trading approval to the stock exchange(s) within seven working days from the date of grant of listing approval. Non-compliance with this requirement will attract fines as specified in the said SEBI circular.

Company Communication

The disclosure was filed by Sanjana Gupta, Company Secretary cum Compliance Officer of Nexome Capital Markets Limited, in accordance with Regulation 30 of SEBI (LODR) Regulations, 2015. The BSE listing approval letter was issued by Marian D'souza, Assistant Vice President, and Gaurav Bajare, Deputy Manager, on behalf of BSE Limited. The company is headquartered at Vaibhav, 4th Floor, 4 Lee Road, Kolkata, West Bengal – 700020.

Historical Stock Returns for Nexome Capital Markets

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+25.26%+11.18%+25.81%+55.72%+252.83%

How will the addition of 19,20,000 new equity shares impact Nexome Capital Markets' promoter shareholding pattern and potential dilution for existing shareholders?

What strategic initiatives or business expansion plans is Nexome Capital Markets likely to fund using the capital raised through this preferential allotment?

Will Nexome Capital Markets seek trading approval from the National Stock Exchange (NSE) in addition to BSE, and how might dual-listing affect the stock's liquidity?

like18
dislike

More News on Nexome Capital Markets

1 Year Returns:+55.72%